Intercept Pharma (ICPT) Management Call Thoughts About Data Delay to July from June - Piper Sandler
Tweet Send to a Friend
Piper Sandler Yasmeen Rahimi Overweight Intercept Pharmaceuticals (NASDAQ: ICPT) price target of $82.00 after meeting with management to discuss reasoning ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
